CClinicalTrials.gg
CompletedNCT03755271Updated Nov 27, 2018

Hemodynamic Monitoring in Obstetrics

An observational study in Hypotension, sponsored by University of Catania. Completed at 1 site in Italy. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2018-11-27.

Sponsored by University of Catania · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
148
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Spinal anesthesia has long been considered the first choice technique in caesarean section, but although it is a reliable and safe procedure, it is in some cases associated with undesirable effects. Maternal hypotension after sub-arachnoid anesthesia is a reduction in systolic blood pressure below 100 mmHg or a decrease of 20% compared to baseline values. According to some authors, maternal hypotension occurs up to 80% in women undergoing caesarean section after spinal anesthesia. In order to reduce the incidence of maternal hypotension, some measures can be taken:

  • a reduction of aorto-caval compression by manual displacement of the uterus on the left;
  • hemodynamic monitoring;
  • administration of fluids;
  • optimization of the dosage of the local anesthetic;
  • use of vasopressors.

The main objective of the study is to investigate, through the use of a continuous non-invasive hemodynamic monitoring system (Clearsight® - Edwards Lifesciences), the incidence of hypotension in pregnant women at risk undergoing spinal anesthesia due to elective cesarean section.

Read the detailed description

In this prospective observational not-for profit study, 128 patients will be enrolled to measure the incidence of hypotension during spinal anesthesia for elective cesarean section. On the occasion of the preoperative visit, all patients to be subjected to elective cesarean section will be subjected to the Postural Change Test (PCT), a predictive test for maternal hypotension during spinal anesthesia that evaluate changes in heart rate of pregnant women following postural changes. Specifically, after monitoring the heart rate in the supine position, the patient is asked to change decubitus (from supine to left lateral and then back to supine). The test is positive if the patient's heart rate changes more than 10% from baseline.

Once arrived in the obstetric emergency department, parturients with positive Postural Change Test will be subjected to cannulation of a peripheral vein through a 18-20 Gauge needle cannula and the Clearsight hemodynamic monitoring system will be placed on a finger. The investigators will then proceed to the detection of the following parameters:

  • Mean Blood Pressure (MAP);
  • Heart Rate (HR);
  • Stroke volume (SV);
  • Stroke volume Index (SVI);
  • Cardiac Index (CI). These data will be collected and reported in the data sheet of the study, at different time points (T0 - T9). Basal values will be collected at T0 and T1: at T0 when the patient is in the supine position and at T1 when the patient is in a lateral position. The investigators will then proceed to the administration of a crystalloid bolus (10 ml/kg) and to the execution of spinal anesthesia (T2). The spinal block needle will be inserted, compatibly to the patient's anatomical conditions, at the L3-L4 / L4-L5 spaces. 0.5% hyperbaric Bupivacaine (5 mg/ml) will be administered at a dose depending on the patient's weight and height.

Once the spinal block has been performed, the patient will be immediately placed in a supine position. The investigators will then continue monitoring the parameters listed above using Clearsight® (SV, SVI, MAP, CI) at 2-minute intervals in the phases following spinal anesthesia:

  • T3: 2 minutes after spinal anesthesia,
  • T4: 4 minutes after spinal anesthesia,
  • T5: 6 minutes after spinal anesthesia,
  • T6: 8 minutes after spinal anesthesia. The other measurements will be made at skin incision (T7), uterine incision (T8) and extraction (T9).

Any hemodynamic changes (MAP \<60 mmHg or CI \<2.5), under volemic optimization conditions, will be treated by administration of vasoconstrictors (Etilefrine, intravenous bolus of 1-3 mg).

At the afterbirth, the investigators will proceed to the infusion of liquids and uterotonic according regimens in use at the unit of Anesthesia and Intensive Care of the Universitary Hospital "G. Rodolico" of Catania.

Given the descriptive nature of the study, a formal calculation of the sample size was not made. As secondary end-points, the Stroke Volume variation following spinal anesthesia, the amount of fluids administered, the vasoconstrictor doses used, diuresis, the Apgar index and the fetal pH will be measured. The number of hypotension episodes not detected by the traditional blood pressure monitoring system but detected by the Clearsight system will also be recorded. For the qualitative variables, the absolute frequencies and the percentage frequencies will be calculated. For the quantitative variables, if with normal distribution, mean and standard deviation will be calculated; if with not normal distribution, median and interquartile range will be calculated.

The normality of the distribution will be evaluated through the Kolmogorov-Smirnoff test.

02

Conditions studied

  • Hypotension

Browse trials for

Keywords

  • Intraoperative hypotension
  • Caesarean section
  • Spinal anesthesia
03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's enrollment of 148 is above the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

University of Catania is the lead sponsor of 68 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

148 pregnant women, at risk of developing hypotension, undergoing spinal anesthesia for elective Caesarean section at the Universitary Hospital "G. Rodolico" of Catania

Inclusion criteria

  • Age between 18 and 40 years
  • American Society of Anesthesiologists (ASA) Classification I-II
  • Positive Postural Change Test (PCT)
  • Signature of informed consent

Exclusion criteria

Exclusion Criteria:

  • Age less than 18 years or above 40 years
  • American Society of Anesthesiologists (ASA) Classification III-V
  • Negative Postural Change Test (PCT)
  • Refusal by the parturients to sign the informed consent
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
148 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of hypotension assessed through the use of the non-invasive hemodynamic monitoring system ClearSight

    Time frame: Intraoperatively

Secondary outcomes

  1. Modifications of Stroke Volume (SV) from basal

    Time frame: 2 minutes after spinal anesthesia

  2. Modifications of Stroke Volume (SV) from basal

    Time frame: 4 minutes after spinal anesthesia

  3. Modifications of Stroke Volume (SV) from basal

    Time frame: 6 minutes after spinal anesthesia

  4. Modifications of Stroke Volume (SV) from basal

    Time frame: 8 minutes after spinal anesthesia

  5. Modifications of Stroke Volume (SV) from basal

    Time frame: 2 minutes after cutaneous incision

  6. Modifications of Stroke Volume (SV) from basal

    Time frame: 2 minutes after uterine incision

  7. Modifications of Stroke Volume (SV) from basal

    Time frame: 2 minutes after extraction

  8. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 2 minutes after spinal anesthesia

  9. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 4 minutes after spinal anesthesia

  10. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 6 minutes after spinal anesthesia

  11. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 8 minutes after spinal anesthesia

  12. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 2 minutes after cutaneous incision

  13. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 2 minutes after uterine incision

  14. Modifications of Stroke Volume Index (SVI) from basal

    Time frame: 2 minutes after extraction

  15. Modifications of Cardiac Index (CI) from basal

    Time frame: 2 minutes after spinal anesthesia

  16. Modifications of Cardiac Index (CI) from basal

    Time frame: 4 minutes after spinal anesthesia

  17. Modifications of Cardiac Index (CI) from basal

    Time frame: 6 minutes after spinal anesthesia

  18. Modifications of Cardiac Index (CI) from basal

    Time frame: 8 minutes after spinal anesthesia

  19. Modifications of Cardiac Index (CI) from basal

    Time frame: 2 minutes after cutaneous incision

  20. Modifications of Cardiac Index (CI) from basal

    Time frame: 2 minutes after uterine incision

  21. Modifications of Cardiac Index (CI) from basal

    Time frame: 2 minutes after extraction

  22. Need for inotropes and / or vasopressor during surgery

    Doses of inotropes and / or vasopressor administered during surgery

    Time frame: Intraoperatively

  23. Need for fluids administration during surgery

    Volume of fluids administered during surgery for the eventual treatment of hypotension

    Time frame: Intraoperatively

  24. Volume of urine excreted during surgery

    Time frame: Intraoperatively

  25. Evaluation of fetal health through Apgar score

    The Apgar score is determined by evaluating the newborn baby on five simple criteria (skin color, pulse rate, reflex irritability grimace, activity and respiratory effort) on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. The test is done at 1 and 5 minutes after birth and may be repeated later if the score is and remains low. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts.

    Time frame: At 1 and at 5 minute after birth

  26. Number of hypotension episodes not detected by the traditional pressure cuff but detected by the Clearsight system

    Time frame: Intraoperatively

07

Study locations

1 site
  • "G. Rodolico" Presidium of the Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele"
    Catania, 95123, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03755271
Lead sponsor
University of Catania
Collaborators
Marinella Astuto, Carmelo Minardi, Mirko Mineri, Francesco Vasile, Gaetano Joseph Palumbo
Responsible party
Paolo Murabito (Assistant Professor, University of Catania) — Principal investigator
First posted
Nov 27, 2018
Start date
Mar 2, 2018
Primary completion
Jul 20, 2018
Completion
Jul 20, 2018
Last update
Nov 27, 2018

Study contacts

Paolo Murabito, MD
principal investigator · University of Catania
Marinella Astuto, MD
study director · University of Catania

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion